Table 2.
Recipient Characteristic | Hazard Ratio | P-value |
---|---|---|
Age | ||
18 – 25 | REF | |
26 – 35 | 0.84 | 0.008 |
36 – 45 | 0.81 | 0.001 |
46 – 55 | 0.93 | 0.236 |
56 – 65 | 1.12 | 0.031 |
< 65 | 1.41 | <0.001 |
Female vs. Male | 1.08 | 0.003 |
Diagnosis | ||
COPD1 | REF | |
Idiopathic Pulmonary Fibrosis | 1.30 | <0.001 |
Cystic Fibrosis | 0.88 | 0.001 |
Other Fibrosis2 | 1.23 | <0.001 |
Pulmonary Hypertension | 1.29 | <0.001 |
Bronchiectasis | 1.08 | 0.306 |
Lymphangiomyomatosis | 0.43 | <0.001 |
Other | 1.07 | 0.409 |
Body Mass Index | 1.02 | <0.001 |
Creatinine | 1.15 | <0.001 |
Total Bilirubin | 1.02 | <0.001 |
Pulmonary Variables | ||
Oxygen Requirement, L/min | 1.06 | <0.001 |
Carbon Dioxide, mEq/L | 0.995 | 0.003 |
FEV1 (L) | 1.003 | <0.001 |
FVC (L) | 1.000 | 0.711 |
6 minute walk test < 150 feet | 1.24 | <0.001 |
Mechanical ventilation | 1.18 | 0.031 |
Hemodynamic Variables | ||
Cardiac Output (L/min) | 0.966 | 0.008 |
Wedge Pressure (mm Hg) | 0.998 | 0.468 |
Systolic Pulmonary Artery Pressure | 1.003 | 0.004 |
Recipient Viral Status | ||
CMV positive status | 1.017 | 0.584 |
EBV positive status | 0.86 | 0.003 |
HCV positive status | 1.24 | 0.039 |
Co-morbidities | ||
Diabetes | 1.13 | 0.002 |
Hypertension | 1.16 | <0.001 |
Cancer | 1.10 | 0.232 |
Transfusion History | 1.30 | <0.001 |
Peptic Ulcer | 1.18 | 0.011 |
Cerebral Vascular | 1.36 | 0.061 |
Corticosteroid user | 1.22 | <0.001 |
COPD: Chronic Obstructive Pulmonary Disease and alpha-1 antitrypsin deficiency
Other fibrosis includes: rheumatoid arthritis, wegner’s granulomatosis-restrictive, pulmonary telengectasia, mixed connective tissue disease, polymyositis, silicosis, CREST, scleroderma, collagen vascular disease, connective tissue disease, desquamative interstitial pneumonitis, lymphocytic interstitial pneumonitis, restrictive lung disease, sjogren’s, occupational lung disease-other, pulmonary fibrosis(other specify).